Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Balleyguier

Showing results (41-50 of 50) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 50 results.
Bulletin Du Cancer|November 19, 2009
[New drugs and targeted therapeutic agents in ovarian cancer]T de La Motte Rouge, M-C Petrella, J Michels, et al.
Gynecologie, Obstetrique, Fertilite & Senologie|September 6, 2021
[Fertility preservation in cervical cancer, analysis of 30 years of practice and immersion in future developments]M Bréban-Kehl, F Zaccarini, C Sanson, et al.
European Journal of Cancer (Oxford, England : 1990)|November 29, 2017
Patterns of responses in metastatic NSCLC during PD-1 or PDL-1 inhibitor therapy: Comparison of RECIST 1.1, irRECIST and iRECIST criteriaM Tazdait, L Mezquita, J Lahmar, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|August 3, 2010
[Accelerated partial breast irradiation: bifractionated 40Gy in one week. A French pilot phase II study]C Bourgier, C Pichenot, R Verstraet, et al.
European Journal of Cancer (Oxford, England : 1990)|June 10, 2014
Actinomycin D, cisplatin, and etoposide regimen is associated with almost universal cure in patients with high-risk gestational trophoblastic neoplasiaC Even, P Pautier, P Duvillard, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 6, 2020
Tocilizumab, an anti-IL-6 receptor antibody, to treat COVID-19-related respiratory failure: a case reportJ-M Michot, L Albiges, N Chaput, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 13, 2010
Inter- and intraobserver consistency in assessing eligibility for bevacizumab (BVZ) in non-small-cell lung cancer (NSCLC) patients with centrally located tumorsF Barlési, C Balleyguier, B Besse, et al.
The Journal of Clinical Endocrinology and Metabolism|June 24, 2005
Breast inflammatory gigantomastia in a context of immune-mediated diseasesP Touraine, N Youssef, M A Alyanakian, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 13, 2018
Modulation of Rb phosphorylation and antiproliferative response to palbociclib: the preoperative-palbociclib (POP) randomized clinical trialM Arnedos, M A Bayar, B Cheaib, et al.
Diagnostic and Interventional Imaging|March 20, 2019
Five simultaneous artificial intelligence data challenges on ultrasound, CT, and MRIN Lassau, T Estienne, P de Vomecourt, et al.
Pageof 5

Showing results (41-50 of 50) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 50 results.
Bulletin Du Cancer|November 19, 2009
[New drugs and targeted therapeutic agents in ovarian cancer]T de La Motte Rouge, M-C Petrella, J Michels, et al.
Gynecologie, Obstetrique, Fertilite & Senologie|September 6, 2021
[Fertility preservation in cervical cancer, analysis of 30 years of practice and immersion in future developments]M Bréban-Kehl, F Zaccarini, C Sanson, et al.
European Journal of Cancer (Oxford, England : 1990)|November 29, 2017
Patterns of responses in metastatic NSCLC during PD-1 or PDL-1 inhibitor therapy: Comparison of RECIST 1.1, irRECIST and iRECIST criteriaM Tazdait, L Mezquita, J Lahmar, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|August 3, 2010
[Accelerated partial breast irradiation: bifractionated 40Gy in one week. A French pilot phase II study]C Bourgier, C Pichenot, R Verstraet, et al.
European Journal of Cancer (Oxford, England : 1990)|June 10, 2014
Actinomycin D, cisplatin, and etoposide regimen is associated with almost universal cure in patients with high-risk gestational trophoblastic neoplasiaC Even, P Pautier, P Duvillard, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 6, 2020
Tocilizumab, an anti-IL-6 receptor antibody, to treat COVID-19-related respiratory failure: a case reportJ-M Michot, L Albiges, N Chaput, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 13, 2010
Inter- and intraobserver consistency in assessing eligibility for bevacizumab (BVZ) in non-small-cell lung cancer (NSCLC) patients with centrally located tumorsF Barlési, C Balleyguier, B Besse, et al.
The Journal of Clinical Endocrinology and Metabolism|June 24, 2005
Breast inflammatory gigantomastia in a context of immune-mediated diseasesP Touraine, N Youssef, M A Alyanakian, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 13, 2018
Modulation of Rb phosphorylation and antiproliferative response to palbociclib: the preoperative-palbociclib (POP) randomized clinical trialM Arnedos, M A Bayar, B Cheaib, et al.
Diagnostic and Interventional Imaging|March 20, 2019
Five simultaneous artificial intelligence data challenges on ultrasound, CT, and MRIN Lassau, T Estienne, P de Vomecourt, et al.
Pageof 5